Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Lethargy, Exaggerated startle response, Decreased liver function, and Dystonia and others; and very common findings: Low muscle tone (hypotonia). 51 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 18 | Exaggerated startle response, Dystonia, Seizure |
GCSH encodes glycine cleavage system protein H (173 aa). The glycine cleavage system catalyzes the degradation of glycine. The H protein (GCSH) shuttles the methylamine group of glycine from the P protein (GLDC) to the T protein (GCST). Highest expression in Brain Spinal cord cervical c-1 (20.7 TPM) and Thyroid (17.5 TPM).
Multiple mitochondrial dysfunctions syndrome 7 is caused by mutations in the GCSH gene on chromosome 16.
The GCSH protein participates in LIPT2 transfers octanoyl group to GCSH, LIAS synthesizes lipoyl-GCSH, and LIPT1 transfers lipoyl group from lipoyl-GCSH to DLAT pathways.
GCSH is classified as a druggable target (Enzyme category) with score 0.0.
Genetic testing for GCSH is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 48 always present features, 1 very common feature, 2 common features.
No clinical trials have been registered for multiple mitochondrial dysfunctions syndrome 7.
7 publications have been identified in PubMed for multiple mitochondrial dysfunctions syndrome 7. Research spans Review / Meta-Analysis (57%), Basic Science / Preclinical (29%), and Epidemiology / Natural History (14%).
Jiang H (2025). [PMID: 39227420](https://pubmed.ncbi.nlm.nih.gov/39227420/). *Journal of human genetics*. [Epidemiology / Natural History]
Hu Z (2025). [PMID: 41337580](https://pubmed.ncbi.nlm.nih.gov/41337580/). *Sci Adv*. [Basic Science / Preclinical]
Cappuccio G (2025). [PMID: 41497664](https://pubmed.ncbi.nlm.nih.gov/41497664/). *bioRxiv*. [Basic Science / Preclinical]
Lu Y (2025). [PMID: 41260099](https://pubmed.ncbi.nlm.nih.gov/41260099/). *Redox Biol*. [Review / Meta-Analysis]
Ijaz A (2025). [PMID: 40790757](https://pubmed.ncbi.nlm.nih.gov/40790757/). *Orphanet J Rare Dis*. [Review / Meta-Analysis]
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 3:01 PM UTC
Online Mendelian Inheritance in Man
Digestive system
2 |
Decreased liver function, Feeding difficulties |
Muscles | 2 | Low muscle tone (hypotonia), Axial hypotonia |
Lungs and breathing | 2 | Apnea, Respiratory failure requiring assisted ventilation |
Lab test results | 1 | Increased CSF glycine concentration |
Metabolism | 1 | Metabolic acidosis |
Head and neck | 1 | Secondary microcephaly |
Blood and immune system | 1 | Low platelet count (thrombocytopenia) |
Li S (2025). [PMID: 40897695](https://pubmed.ncbi.nlm.nih.gov/40897695/). *Cell Death Discov*. [Review / Meta-Analysis]
AI-curated news mentioning multiple mitochondrial dysfunctions syndrome 7
Updated May 26, 2026
A recent case study highlights multiple mitochondrial dysfunctions syndrome 1, contributing to the understanding of this rare condition. The literature review provides insights into clinical manifestations and potential therapeutic approaches.